Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Avacta Group (AVCT) Share News

IN BRIEF: Avacta Group issues 3.8 million shares to make repayment

21st Jul 2023 16:00

Avacta Group PLC - Wetherby, England-based life sciences company developing targeted oncology drugs and diagnostics - Issues 3.8 million new shares of 10 pence each to settle quarterly principal of GBP2.6 million and interest repayment of GBP760,000. After settlement of the quarterly repayment, the principal remaining under the convertible bond will be reduced by GBP2.6 million to GBP44.2 million. Read More

UK shareholder meetings calendar - next 7 days

21st Jun 2023 15:43

Avacta says AVA6000 fifth dose escalation results "very favourable"

21st Jun 2023 09:58

(Alliance News) - Avacta Group PLC on Wednesday said it has completed the fifth dose escalation cohort in its phase 1 clinical study of AVA6000. Read More

IN BRIEF: Avacta says no fundraising imminent after market speculation

19th Jun 2023 12:43

Avacta Group PLC - Wetherby, England-based life sciences company developing targeted oncology drugs and diagnostics - Reponds to recent market speculation regarding a possible fundraising. Says no fundraising is imminent. Notes it has a strong cash balance of GBP27 million as at May 31 and expects strong new flow in the company months. Read More

LONDON MARKET OPEN: Stocks falter amid weaker outlook for China

19th Jun 2023 09:09

(Alliance News) - Stock prices in London opened lower on Monday, ahead of more interest rate decisions, and amid fears for China's slowing economic recovery. Read More

LONDON BRIEFING: Severn Trent deal sized up by CMA; Coca-Cola HBC buys

19th Jun 2023 07:53

(Alliance News) - Stocks in London are called lower on Monday, ahead of more central bank decisions, while a meeting between US Secretary of State Antony Blinken and his Chinese counterpart put relations between the two nations back under the spotlight. Read More

Avacta sees shares rise on new equity payment for South Korea venture

5th Jun 2023 12:06

(Alliance News) - Avacta Group PLC on Monday celebrated "rapid" progress on its joint venture in South Korea, following a second equity payment. Read More

Avacta enhances rapid test portfolio with GBP7.4 million Coris buy

1st Jun 2023 10:24

(Alliance News) - Avacta Group PLC on Thursday said that it has bought Coris Bioconcept SRL, adding a range of professional-use rapid tests to its product portfolio. Read More

TRADING UPDATES: Volex wins contract; Engage XR revenue jumps

27th Apr 2023 14:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payout

25th Apr 2023 14:39

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

18th Apr 2023 15:47

Avacta opens first two clinical investigator sites in US for AVA6000

6th Apr 2023 12:14

(Alliance News) - Avacta Group PLC on Thursday said it opened its first two clinical investigator sites for the phase 1 clinical trial of AVA6000 on Wednesday, under it US investigational new drug application. Read More

Avacta doses first patient in fifth cohort of AVA6000 phase 1 study

5th Apr 2023 12:12

(Alliance News) - Avacta Group PLC on Wednesday said the first patient has been dosed in the fifth cohort of the first-in-human phase 1 trial of AVA6000, a novel form of doxorubicin designed to improve its safety and therapeutic index. Read More

SUMMARY: London listings with exposure to Silicon Valley Bank

13th Mar 2023 12:18

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares

17th Jan 2023 16:23

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Avacta raises GBP64 million to finance Launch Diagnostics purchase

8th Nov 2022 13:51

(Alliance News) - Avacta Group PLC on Tuesday closed its GBP2.0 million open offer of shares, bringing its total fundraise to GBP64.0 million. Read More

Avacta plans to raise GBP62 million; buys Launch Diagnostics

18th Oct 2022 12:40

(Alliance News) - Avacta Group PLC on Tuesday announced a GBP62.0 million fundraise, which will be partially used to finance its acquisition of Launch Diagnostics Holdings Ltd for up GBP37 million. Read More

Avacta narrows loss, multiplies revenue thanks to Therapeutics divison

29th Sep 2022 11:30

(Alliance News) - Avacta Group PLC on Thursday reported a narrowed interim loss as it multiplied its revenue significantly thanks to a strong performance from its Therapeutics division. Read More

AIM WINNERS & LOSERS: Avacta gets approval; Jubilee's Roan at capacity

5th Sep 2022 11:07

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Avacta shares up as drug approved for soft tissue sarcoma treatment

5th Sep 2022 10:10

(Alliance News) - Avacta Group PLC on Monday said it received approval for its AVA6000 for treatment of soft tissue sarcoma. Read More

FTSE 100 Latest

Value9,177.24

Change0.00